Skip to content
Search

Latest Stories

P2U forges ties with travel insurance broker

A specialist medical travel insurance provider has joined forces with Pharmacy2U in an alliance aimed at providing guidance and support to travellers living with medical conditions.

The partnership will see Pharmacy2U’s superintendent pharmacist, Phil Day, become Just Travel Cover’s medical consultant and brand ambassador. He will contribute to the specialist broker’s website with a series of guides to answer questions about travelling with health conditions including diabetes, heart conditions and cancer.


Day, who became a qualified Independent Prescriber in 2011, was also the lead pharmacist in a University College London study to assess the benefits of pharmacist-led interventions, for patients taking long term medicines. 

Dale Robinson, marketing manager at Just Travel Cover, said: “We’ve been working with Pharmacy2U for some time, calling on their expert knowledge and guidance for our customers, many of whom are living with medical conditions; I’m delighted that Phil is now part of that mix by publishing online guides that will help us provide useful resources to our clients and provide a real voice of authority." 

Day commented: “The number of people living with medical conditions is rising, but that shouldn’t stop them enjoying holidays and we know that getting appropriate medical Travel Insurance is a vital part of that, now more than ever”.

Mr Robinson added: “We hope that by providing people with reliable, trustworthy and credible information about travelling with pre-existing conditions they can make smart decisions before their holiday and during it”.

 Just Travel Cover compare prices and cover from a range of specialist insurers and underwriters, providing Travel Insurance for all ages and hundreds of medical conditions.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less